Eiropas Savienība - latviešu - EMA (European Medicines Agency)

pierre fabre medicament - propranolola hidrohlorīds - hemangioma - beta blocking agents - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.

Latvija - latviešu - Zāļu valsts aģentūra

olainfarm, as, latvia - propranolola hidrohlorīds - tablete - 10 mg

Latvija - latviešu - Zāļu valsts aģentūra

olainfarm, as, latvia - propranolola hidrohlorīds - tablete - 40 mg